IDEXX LABORATORIES INC /DE Deferred Income Tax Expense (Benefit) in USD from Q1 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Idexx Laboratories Inc /De quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to 2024.
  • Idexx Laboratories Inc /De Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$2.57M, a 31.6% increase year-over-year.
  • Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2024 was -$24.2M, a 49.9% increase from 2023.
  • Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2023 was -$48.3M, a 38.5% decline from 2022.
  • Idexx Laboratories Inc /De annual Deferred Income Tax Expense (Benefit) for 2022 was -$34.9M, a 915% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

IDEXX LABORATORIES INC /DE Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$2.57M +$1.19M +31.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 -$3.76M +$1.27M +25.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 -$5.03M -$10.3M -196% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q1 2021 $5.24M +$2.39M +83.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.85M -$441K -13.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $3.29M +$289K +9.62% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q1 2018 $3.01M +$1.06M +54.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $1.94M -$579K -23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 $2.52M +$1.96M +346% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q1 2015 $565K +$1.4M Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q1 2014 -$835K -$2M -171% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q1 2013 $1.17M +$707K +153% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q1 2012 $462K -$2.04M -81.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q1 2011 $2.5M +$1.73M +225% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q1 2010 $769K Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21

IDEXX LABORATORIES INC /DE Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$24.2M +$24.1M +49.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 -$48.3M -$13.4M -38.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 -$34.9M -$31.4M -915% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-21
2021 -$3.44M +$33.3M +90.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$36.7M -$42.7M -709% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $6.03M +$4.89M +431% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-16
2018 $1.14M +$9.05M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 -$7.92M -$28.5M -138% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $20.6M +$15.5M +301% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
2015 $5.14M +$4.31M +520% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $830K -$1.24M -60% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $2.07M +$4.04M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-17
2012 -$1.97M -$7.97M -133% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-17
2011 $6M +$6.9M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-18
2010 -$908K Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.